
Robert A. Zeman
Examiner (ID: 12430, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1326 |
| Issued Applications | 557 |
| Pending Applications | 268 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20437469
[patent_doc_number] => 12508290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Use of
[patent_app_type] => utility
[patent_app_number] => 18/183544
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 0
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/183544 | Use of | Mar 13, 2023 | Issued |
Array
(
[id] => 19938902
[patent_doc_number] => 12311016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Biomarkers and immunogenic compositions for filarial parasites
[patent_app_type] => utility
[patent_app_number] => 18/173288
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10662
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173288 | Biomarkers and immunogenic compositions for filarial parasites | Feb 22, 2023 | Issued |
Array
(
[id] => 18449554
[patent_doc_number] => 20230190830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITION FOR PREVENTING, IMPROVING OR TREATING BENIGN PROSTATIC HYPERPLASIA OR ALOPECIA, COMPRISING HEAT-KILLED PROBIOTICS AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/168526
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168526 | COMPOSITION FOR PREVENTING, IMPROVING OR TREATING BENIGN PROSTATIC HYPERPLASIA OR ALOPECIA, COMPRISING HEAT-KILLED PROBIOTICS AS ACTIVE INGREDIENT | Feb 12, 2023 | Pending |
Array
(
[id] => 18649437
[patent_doc_number] => 20230295248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/153727
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153727
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153727 | STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF | Jan 11, 2023 | Pending |
Array
(
[id] => 18690988
[patent_doc_number] => 20230321166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => FECAL FUNGOME AND THERAPEUTIC EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 18/090413
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18090413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/090413 | Fecal fungome and therapeutic efficacy of fecal microbiota transplantation | Dec 27, 2022 | Issued |
Array
(
[id] => 18266265
[patent_doc_number] => 20230087507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => Pet Food Compositions Including Probiotics and Methods of Manufacture and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/993310
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993310 | Pet food compositions including probiotics and methods of manufacture and use thereof | Nov 22, 2022 | Issued |
Array
(
[id] => 18673043
[patent_doc_number] => 20230310515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/993329
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993329 | COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND OTHER DISEASES | Nov 22, 2022 | Abandoned |
Array
(
[id] => 18389912
[patent_doc_number] => 20230158130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Compositions and Methods for Generating Tick Immunity
[patent_app_type] => utility
[patent_app_number] => 18/056151
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056151
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056151 | Compositions and Methods for Generating Tick Immunity | Nov 15, 2022 | Pending |
Array
(
[id] => 18238284
[patent_doc_number] => 20230070595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
[patent_app_type] => utility
[patent_app_number] => 17/986424
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17986424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/986424 | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations | Nov 13, 2022 | Issued |
Array
(
[id] => 18227934
[patent_doc_number] => 20230066928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => Novel Bifidobacterium Genus Bacterium
[patent_app_type] => utility
[patent_app_number] => 18/047477
[patent_app_country] => US
[patent_app_date] => 2022-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047477
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047477 | Bifidobacterium genus bacterium | Oct 17, 2022 | Issued |
Array
(
[id] => 18612352
[patent_doc_number] => 20230279084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ANTIBODIES TO BOTULINUM NEUROTOXINS
[patent_app_type] => utility
[patent_app_number] => 18/046751
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046751
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046751 | ANTIBODIES TO BOTULINUM NEUROTOXINS | Oct 13, 2022 | Abandoned |
Array
(
[id] => 19989602
[patent_doc_number] => 20250127824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => BACTERIAL STRAIN USED IN THE PREVENTION AND/OR TREATMENT OF INFLAMMATORY PATHOLOGIES
[patent_app_type] => utility
[patent_app_number] => 18/691975
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691975 | BACTERIAL STRAIN USED IN THE PREVENTION AND/OR TREATMENT OF INFLAMMATORY PATHOLOGIES | Sep 15, 2022 | Pending |
Array
(
[id] => 20506047
[patent_doc_number] => 12540316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-03
[patent_title] => Polypeptides having protease activity and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 17/931280
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20351
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931280 | Polypeptides having Protease Activity and Polynucleotides Encoding Same | Sep 11, 2022 | Pending |
Array
(
[id] => 18451550
[patent_doc_number] => 20230192828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/930219
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930219 | IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES | Sep 6, 2022 | Pending |
Array
(
[id] => 18169441
[patent_doc_number] => 20230036052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => MODIFIED PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/929862
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929862 | MODIFIED PROTEIN | Sep 5, 2022 | Pending |
Array
(
[id] => 18242879
[patent_doc_number] => 20230075190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OR PREVENTION OF CONDITIONS ASSOCIATED WITH HYPERPROLIFERATIVE CELLULAR DIVISION, DIABETES, IMMUNODEFICIENCY DISEASES, ALZHEIMER'S DISEASE OR AUTOIMMUNE DISEASES, AND TESTING SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/896847
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/896847 | COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OR PREVENTION OF CONDITIONS ASSOCIATED WITH HYPERPROLIFERATIVE CELLULAR DIVISION, DIABETES, IMMUNODEFICIENCY DISEASES, ALZHEIMER'S DISEASE OR AUTOIMMUNE DISEASES, AND TESTING SYSTEM AND METHOD | Aug 25, 2022 | Pending |
Array
(
[id] => 19601104
[patent_doc_number] => 20240391984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => MODIFIED KAPPA LIGHT CHAIN-BINDING POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/682409
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682409
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682409 | MODIFIED KAPPA LIGHT CHAIN-BINDING POLYPEPTIDES | Aug 23, 2022 | Pending |
Array
(
[id] => 18404598
[patent_doc_number] => 20230165949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => CLOSTRIDIUM DIFFICILE ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/821730
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821730
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821730 | None | Aug 22, 2022 | Issued |
Array
(
[id] => 18070592
[patent_doc_number] => 11529408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
[patent_app_type] => utility
[patent_app_number] => 17/881131
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 26375
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881131 | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations | Aug 3, 2022 | Issued |
Array
(
[id] => 18075931
[patent_doc_number] => 20220401543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/815221
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815221 | VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION | Jul 26, 2022 | Pending |